Heme | Molecular

Bone Marrow Report Template

Generate

No flow cytometry


With flow cytometry


ALC ×

[−] CBC

 

  xxxx-
xx-xx
WBC 
RBC 
HGB7.7
HCT22.8
MCV 
MCHC 
RDW 
PLT242
   
polychrom 
NRBC0.04
sum abs54.79S61.64S
neut abs7.6
lymph abs0.4
lymph var abs 
mono abs0.6
eo abs0.3
baso abs0.1
imm gran abs 
sum %1514.6
neut % 
lymph %4.9
lymph var % 
mono %6.2
eo %2.8
baso %0.7
imm gran % 
bands % 
metamyelo % 
myelo % 
promyelo % 
blasts % 
other % 

Warnings

  • Summed leukocyte percentages (14.6%) ≠ 100%

Peripheral blood

Peripheral blood:
The red blood cells are normochromichypochromicnormochromichyperchromic
 and ***microcyticnormocyticmacrocytic
Anisocytosis is ***minimalmildmoderatemarked
Poikilocytosis is ***minimalmildmoderatemarked
morphologies
Polychromasia is increased with circulating nucleated red blood cellsnot increasedmildincreasedincreased with circulating nucleated red blood cells
Neutrophils are increaseddecreasednormal in numberincreased
maturationmorphology.
Blastsblasts
Monocytes are ***decreasednormal in numberincreased
Lymphocytes are decreaseddecreasednormal in numberincreased
morphology
Platelets are normal in numberdecreasednormal in numberincreased
 and ***normal in morphologyvary in sizeinclude a subset of large and/or hypogranular forms.

Bone marrow aspirate

Bone marrow aspirate smear(s)/touch preparation(s): The bone marrow cytologic preparations
***contain adequate cellular marrow particles
Erythroid precursors are ***proportionately decreasedproportionately normal in numberproportionately increasedsparse
***and show full-spectrum maturationand show left-shifted maturation
morphology
Myeloid precursors are ***proportionately decreasedproportionately normal in numberproportionately increasedsparse
***and show full-spectrum maturationand show left-shifted maturation
morphology
Blastsblasts
Megakaryocytes are ***proportionately decreasedproportionately normal in numberproportionately increasedsparse
***morphology
Lymphocyteslymphocytes
Plasma cellsplasma cells

Bone marrow biopsy

Bone marrow core biopsy: 
The bone marrow core biopsy ***cellularity(%)
Erythroid precursors are ***decreasednormal in numberincreased
***and show full-spectrum maturationand show left-shifted maturation
Myeloid precursors are ***decreasednormal in numberincreased
***and show full-spectrum maturationand show left-shifted maturation
The M:E ratio is roughly ***:***.
Megakaryocytes are ***decreasednormal in numberincreased***
  and normal in morphology
and vary in size, with a subset of smaller forms
and include frequent smaller forms


Lymphocyteslymphocytes
Plasma cellsplasma cells
Trabecular bone is ***normalfocally thinnedthinnedsparse
        
The clot section shows similar findings as the core biopsy.
The clot section primarily shows peripheral blood.
The clot section shows ***.

Comment

A definite etiology for the patient's *** is difficult to ascertain by morphology and *** flow cytometry of the current specimen. Overt leukemia or lymphoma is not identified. The overall findings are nonspecific, and the differential diagnosis includes autoimmune disorders, drug or toxin exposure, hormones or growth factors, vitamin or essential element deficiencies, and viral infections, as well as a subtle myeloid neoplasm. A subset of monocytes expresses dim CD56, an atypical feature which can be seen in myeloid neoplasms, but nonspecific and frequently seen as a reactive process, e.g. in association with viral infections. If unexpectedly persistent or increasing, consideration may be given to further studies, if clinically indicated. Correlation with concurrent genetic studies is suggested. Correlation with concurrent genetic and minimal residual disease studies is suggested. Correlation with genetic studies is required for classification. In the absence of a defining genetic abnormality, the current findings meet criteria for ***. The findings may indicate a low-grade myelodysplastic neoplasm (MDS); however, correlation with clinical and molecular genetic findings is required to exclude non-clonal, secondary, or transient dysplasia (e.g., drug and toxin exposure, viral infections, immunologic disorders, nutritional deficiencies (vitamin B12 or copper)). Non-clonal causes of dysplasia must be excluded before the diagnosis of MDS is established.

Flow Cytometry


Top Line


Bone Marrow
Peripheral Blood
CSF
Lymph Node
BAL

Positive
Negative
Indeterminate
Atypical
Non-contributory
Debris

Flow comment


Monocloncal B-cell lymphocytosis
CLL/SLL
CML PB/left shifted grans
Neg CSF cytology
Neg CTCL
Neg CSF B-ALL
Neg myeloid
Neg PB screen
Plasma cell
Neg Low count T/B PB
Neg low count CML
Neg low count LN
Neg low count T-ALL
APL
ALL
CSF Burkitt
MCL
SMZL vs SDRPSBL
FL w/ decreased CD10
Pos B cell
WM/MZL
Neg B-cell LN
Neg BM
Neg BM Screen
Neg plasma cells
Persistent TLGLL
Atypical myeloid
Debris
Neg BAL
Neg PB disclaimer
Large cell disclaimer

Verify
Hairy cell
TNK1/CTCL
TNK2
G/D add on
B-ALL 1
B-ALL 2
T-ALL 1
T-ALL 2
Mast/eos
PCN 1
PCN 2
Screen
B-cell CLL
CML
CMML 1
CMML 2
cytK/L
K/L
AML 1
AML 2
AML 3
UA 4
MDS 1
MDS 2
MDS 3
Erythroid
Megas
BAL CD4:CD8
BPDCN

Atypical cells immunophenotype

Draft